Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
Top Cited Papers
- 1 February 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9610), 387-394
- https://doi.org/10.1016/s0140-6736(08)60202-0
Abstract
No abstract availableFunding Information
- Sanofi
This publication has 18 references indexed in Scilit:
- Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolismAmerican Journal of Hematology, 2007
- Thromboprophylaxis rates in US medical centers: success or failure?Journal of Thrombosis and Haemostasis, 2007
- Hospitals’ compliance with prophylaxis guidelines for venous thromboembolismAmerican Journal of Health-System Pharmacy, 2007
- Venous thromboembolism (VTE) in EuropeThrombosis and Haemostasis, 2007
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Fatal pulmonary embolism in hospitalised patients: a necropsy reviewJournal of Clinical Pathology, 2004
- Use of Venous Thromboembolism Prophylaxis for Surgical Patients: A Multicentre Analysis of Practice in SpainThe European Journal of Surgery, 2001
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Incidence of venous thromboembolism verified by necropsy over 30 years.BMJ, 1991
- PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN *1An International Multicentre TrialThe Lancet, 1975